Back to Authors

Alzubaidi, Sadeer J

0000-0001-7955-170X

Mayo Clinic

From the Division of Interventional Radiology (S.G.N., S.J.A., I.J.P., C.I., M.G.K., J.S.K., A.L.W., R.O.), Department of Radiology (K.S.Z., D.G.M.), and Division of Transplant Surgery (N.N.K., A.K.M.), Mayo Clinic Hospital, 5777 E Mayo Blvd, Phoenix, AZ 8

Citations 2

Percutaneous Image-Guided Ablation of Lung Tumors
Alzubaidi, Sadeer , Liou, Harris , Saini, Gia , Segaran, Nicole , Naidu, Sailendra , Patel, Indravadan , Öklü, Rahmi , Alzubaidi, Sadeer J , Patel, Indravadan J, Oklu, Rahmi , Kriegshauser, J. Scott

Journal of Clinical Medicine | December 10, 2021 | Volume: 10 | Issue: 24 | Pages: 5783

10.3390/jcm10245783 Get It

Tumors of the lung, including primary cancer and metastases, are notoriously common and difficult to treat. Although surgical resection of lung lesions is often indicated, many conditions disqualify patients from being surgical candidates. Percutaneous image-guided lung ablation is a relatively new set of techniques that offers a promising treatment option for a variety of lung tumors. Although there have been no clinical trials to definitively compare its efficacy to those of traditional treatments, lung ablation is widely practiced and generally accepted to be safe and effective. Especially encouraging results have recently emerged for cryoablation, one of the newer ablative techniques. This article reviews the indications, techniques, contraindications, and complications of percutaneous image-guided ablation of lung tumors with special attention to cryoablation and its recent developments in protocol optimization.